MedArrive Buys Inbound Health Assets to Expand Home Care Platform

MedArrive, a provider of technology solutions that optimize in-home care programs, has acquired assets from Inbound Health, an Allina Health spin-out that ceased operations in December 2025. MedArrive also announced the appointment of Ophir Lotan as its new CEO.

When Inbound was introduced in 2022, Minneapolis-based Allina said the new company was providing the full stack of capabilities that are required to scale at-home care models. In a July 2023, interview, Julia Crist, the company’s chief operating officer, gave a glimpse into how the spin-out from Allina came together. But the uncertainty around the federal acute hospital at home waiver policy made it difficult for the company to secure additional capital for operations. 

MedArrive, which has developedf a platform to transform how health systems schedule, route, and manage in‑home care, said that the Inbound Health asset acquisition adds AI-backed patient-navigation capabilities to MedArrive’s platform, helping health systems identify which patients are ready to transition from acute care to the home and route them to the appropriate care setting more efficiently. 

Combined with MedArrive’s logistics platform for scheduling and routing clinicians, the platform enables healthcare organizations to coordinate the complex operational workflows required to deliver care in the home. The acquisition also expands MedArrive’s market presence in the hospital-at-home ecosystem and adds new customer relationships that the company said will help accelerate the company’s growth.

“Healthcare is rapidly moving toward home care models, but the operational systems needed to support that shift at scale still lag behind,” said Lotan in a statement. “MedArrive is focused on building the operational foundation that allows health systems, home health companies and mobile-integrated healthcare companies to confidently expand care beyond hospital walls and make care in the home a core part of how healthcare works.”

The acquisition also strengthens MedArrive’s roadmap around patient discharge intelligence and care transitions, the company said. The technology includes AI-powered patient scoring models and workflow integrations designed to support hospital discharge planning and patient routing into home care programs. These models have been trained across multiple hospital systems, enabling faster validation and deployment as health systems scale home care programs.

New CEO Lotan most recently served as chief product officer at Alto Pharmacy. Prior to Alto, Lotan spent nearly a decade at TytoCare, helping build its virtual care platform.

In 2022, Healthcare Innovation interviewed former CEO Dan Trigub about MedArrive’s partnerships with several managed care companies to close care gaps and provide vaccinations.